RECRUITING

Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.

Official Title

Extracellular Vesicles as Predictors of Antidepressant Outcomes in Pediatric Anxiety (EV-SOPRANO)

Quick Facts

Study Start:2019-11-01
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04221997

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Heidi K Schroeder, BS
CONTACT
513-558-4422
heysehk@uc.edu
Zoe A Neptune, BS
CONTACT
513-558-2866
neptunza@uc.edu

Principal Investigator

Jeffrey R Strawn, MD, FAACAP
PRINCIPAL_INVESTIGATOR
University of Cincinnati

Study Locations (Sites)

University of Cincinnati
Cincinnati, Ohio, 45219
United States

Collaborators and Investigators

Sponsor: University of Cincinnati

  • Jeffrey R Strawn, MD, FAACAP, PRINCIPAL_INVESTIGATOR, University of Cincinnati

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-11-01
Study Completion Date2026-09

Study Record Updates

Study Start Date2019-11-01
Study Completion Date2026-09

Terms related to this study

Additional Relevant MeSH Terms

  • Anxiety Disorders